Hepion Pharmaceuticals Inc (HEPA)

[Giovanni]

ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of therapeutic drugs for the treatment of hepatitis B virus (HBV), announced today that the company will host a conference call and live audio webcast on Monday, June 25, 2018 at 4:30 p.m. ET to discuss recent corporate, business and clinical updates.
Conference Call Information:
Interested participants and investors may access the conference call by dialing 1 [phone] or 1 [phone] and providing audience code 1042879.

An audio webcast will be accessible via the Investors section of ContraVir’s website at http://ir.contravir.com/investor-relations. An archive of the webcast will remain available for 90 days beginning at approximately 5:30 p.m., ET on June 25, 2018.

About ContraVir Pharmaceuticals